DOSSIER · 13F Holders · Q2 2026Healthcare · Biological Products, (No Diagnostic Substances)
IOVA
IOVANCE BIOTHERAPEUTICS INC
300 institutions still hold IOVANCE BIOTHERAPEUTICS INC as of Q2 2026. Tracked across SEC 13F-HR filings, with insider and 13D/G activity surfaced alongside.
CUSIP 462260100·Biological Products, (No Diagnostic Substances)·300 13F holders·last filed Jun 30, 2026
AI Holders Summary · Q2 2026
300 institutions reported IOVA in Q2 2026. BlackRock, Inc. leads at 16.8% of the visible book.
Top holders
Sorted by position value. Source: SEC EDGAR 13F-HR filings.
Page 1 of 15
280 more holders available. Log in →